Portuguese government approves community sites where injection drug users can inject themselves under supervision

NewsGuard 100/100 Score

The Portuguese government has approved the establishment of community sites where injection drug users can inject themselves under supervision, and new measures call for needle-exchange programs to be installed in prisons by 2008, AFP/Today Online reports.

Advocates of injection sites say such services can help prevent needle-sharing, which can help spread HIV.

The measures -- which also call for increased methadone use to treat heroin addicts -- are part of a broader program aimed at "reduc[ing] the consumption of drugs and diminish[ing] their harmful social and health effects," according to a statement from the government.

Portugal in 2000 decriminalized drug use, but selling drugs remains illegal, according to AFP/Today Online (AFP/Today Online, 8/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial